Skip to main content
Fadi Kayali, MD, Oncology, Sarasota, FL

FadiKayaliMD

Oncology Sarasota, FL

Physician

Dr. Kayali is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Kayali's full profile

Already have an account?

  • Office

    600 N Cattlemen Rd
    Suite 200
    Sarasota, FL 34232
    Phone+1 941-377-9993
    Fax+1 941-343-0026

Education & Training

  • University of Louisville School of Medicine
    University of Louisville School of MedicineFellowship, Hematology and Medical Oncology, 2007 - 2010
  • Trinity Health Oakland/Wayne State University
    Trinity Health Oakland/Wayne State UniversityResidency, Internal Medicine, 2004 - 2007
  • St Petersburg Medical State Academy
    St Petersburg Medical State AcademyClass of 1997

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2010 - 2026
  • OK State Medical License
    OK State Medical License 2011 - 2012
  • KY State Medical License
    KY State Medical License 2007 - 2011
  • MI State Medical License
    MI State Medical License 2004 - 2007
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Hospice and Palliative Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc., 2014
  • CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2012-2013

Publications & Presentations

PubMed

Journal Articles

  • A Phase I Clinical Trial of Ruxolitinib in Combination with Nilotinib in Chronic Myeloid Leukemia Patients with Molecular Evidence of Disease  
    Kendra Sweet, Fadi Kayali, Javier Pinilla-Ibarz, Leukemia Research
  • A Phase I Clinical Trial of Ruxolitinib in Combination with Nilotinib in Chronic Myeloid Leukemia Patients with Molecular Evidence of Disease  
    Kendra Sweet, Fadi Kayali, Javier Pinilla-Ibarz, Leukemia Research

Authored Content

  • A Phase I Clinical Trial of Ruxolitinib in Combination with Nilotinib in Chronic Myeloid Leukemia Patients with Molecular Evidence of DiseaseOctober 2018

Other Languages

  • Russian, Arabic, Russian, Arabic